Cyclacel Pharmaceuticals Stock Forecast - Naive Prediction

CYCC Stock  USD 0.41  0.06  17.14%   
The Naive Prediction forecasted value of Cyclacel Pharmaceuticals on the next trading day is expected to be 0.59 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.66. Cyclacel Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Cyclacel Pharmaceuticals stock prices and determine the direction of Cyclacel Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Cyclacel Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
The current year's Asset Turnover is expected to grow to 0.05, whereas Inventory Turnover is projected to grow to (0.01). . The current year's Common Stock Shares Outstanding is expected to grow to about 893.4 K, whereas Net Loss is forecasted to decline to (25.8 M).

Cyclacel Pharmaceuticals Cash Forecast

Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Cyclacel Pharmaceuticals' financial statements to predict how it will affect future prices.
 
Cash  
First Reported
2003-12-31
Previous Quarter
M
Current Value
M
Quarterly Volatility
12.9 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
A naive forecasting model for Cyclacel Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Cyclacel Pharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Cyclacel Pharmaceuticals Naive Prediction Price Forecast For the 1st of December

Given 90 days horizon, the Naive Prediction forecasted value of Cyclacel Pharmaceuticals on the next trading day is expected to be 0.59 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.66.
Please note that although there have been many attempts to predict Cyclacel Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cyclacel Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Cyclacel Pharmaceuticals Stock Forecast Pattern

Backtest Cyclacel PharmaceuticalsCyclacel Pharmaceuticals Price PredictionBuy or Sell Advice 

Cyclacel Pharmaceuticals Forecasted Value

In the context of forecasting Cyclacel Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cyclacel Pharmaceuticals' downside and upside margins for the forecasting period are 0 and 8.64, respectively. We have considered Cyclacel Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.41
0.59
Expected Value
8.64
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Cyclacel Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Cyclacel Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria115.682
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0752
MAPEMean absolute percentage error0.1053
SAESum of the absolute errors4.6639
This model is not at all useful as a medium-long range forecasting tool of Cyclacel Pharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Cyclacel Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Cyclacel Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cyclacel Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyclacel Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.358.40
Details
Intrinsic
Valuation
LowRealHigh
0.173.3711.42
Details
1 Analysts
Consensus
LowTargetHigh
11.1512.2513.60
Details

Other Forecasting Options for Cyclacel Pharmaceuticals

For every potential investor in Cyclacel, whether a beginner or expert, Cyclacel Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cyclacel Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cyclacel. Basic forecasting techniques help filter out the noise by identifying Cyclacel Pharmaceuticals' price trends.

View Cyclacel Pharmaceuticals Related Equities

 Risk & Return  Correlation

Cyclacel Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cyclacel Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cyclacel Pharmaceuticals' current price.

Cyclacel Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Cyclacel Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cyclacel Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Cyclacel Pharmaceuticals stock market strength indicators, traders can identify Cyclacel Pharmaceuticals entry and exit signals to maximize returns.

Cyclacel Pharmaceuticals Risk Indicators

The analysis of Cyclacel Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cyclacel Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cyclacel stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Cyclacel Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cyclacel Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cyclacel Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cyclacel Pharmaceuticals Stock:
Check out Historical Fundamental Analysis of Cyclacel Pharmaceuticals to cross-verify your projections.
For information on how to trade Cyclacel Stock refer to our How to Trade Cyclacel Stock guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclacel Pharmaceuticals. If investors know Cyclacel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclacel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(27.40)
Revenue Per Share
0.044
Quarterly Revenue Growth
(0.99)
Return On Assets
(1.03)
Return On Equity
(5.71)
The market value of Cyclacel Pharmaceuticals is measured differently than its book value, which is the value of Cyclacel that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclacel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cyclacel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclacel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cyclacel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclacel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cyclacel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclacel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.